The relationship between GLP-1 agonists and sleep is complex because while some people experience initial sleep disruption, others report improved sleep quality as weight decreases and metabolic health improves
Meanwhile, dual agonists, which target and activate both the GLP-1 (Glucagon-like peptide-1) receptor and the GIP (glucose-dependent insulinotropic polypeptide) receptor, and triple agonists (targeting the GLP-1+GIP+Glucagon receptors) are also showing promise
Practical Application Weight loss plans that utilize retatrutide or semaglutide perform optimally when combined with straightforward, practical actions
Carbohydrates dont need to be eliminated
doi: 10.1001/jamanetworkopen.2024.33326
By acting on those three hormone pathways at once, retatrutide is thought to: Reduce appetite and increase fullness, so eating less feels natural rather than forced